1. Home
  2. YAAS vs IXHL Comparison

YAAS vs IXHL Comparison

Compare YAAS & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

N/A

Current Price

$2.79

Market Cap

41.8M

Sector

Technology

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$3.19

Market Cap

37.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
YAAS
IXHL
Founded
2018
2001
Country
China
Australia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.8M
37.0M
IPO Year
2023
2024

Fundamental Metrics

Financial Performance
Metric
YAAS
IXHL
Price
$2.79
$3.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
173.4K
95.5K
Earning Date
01-29-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.16
52 Week High
$4.98
$6.39

Technical Indicators

Market Signals
Indicator
YAAS
IXHL
Relative Strength Index (RSI) 79.63 51.64
Support Level $0.75 $2.79
Resistance Level $4.98 $3.68
Average True Range (ATR) 0.38 0.15
MACD 0.16 0.04
Stochastic Oscillator 50.28 82.29

Price Performance

Historical Comparison
YAAS
IXHL

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: